探索N4基因酶合成的突变基因酶N-基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因
Martyna Koplūnaitė1, Kamilė Butkutė1, Jonita Stankevičiūtė1
1Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio Av. 7, LT-10257 Vilnius, Lithuania.
Molecules (Basel, Switzerland)
|August 29, 2024
概括
这项研究介绍了一种化学酶方法,用于合成修改后的胺单酸盐. 突变核酸酶被设计为化新型化合物,扩大它们的基质范围用于抗病毒和抗瘤应用.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药用化学 医学化学
背景情况:
- 核化物,核酸和类似物在生物研究和作为治疗剂 (抗病毒,抗质) 中至关重要.
- 酶性酸化为核酸修饰的化学方法提供了一个可行的替代方案.
研究的目的:
- 开发一种用于新型N4修饰型细胞单酸盐的化学酶合成方法.
- 为了设计突变的核酸激酶,扩展基质特异性用于新型核酸酸化.
主要方法:
- 新型N4修饰型细胞因子的化学合成.
- 使用野生类型和突变核酸酶,包括Drosophila melanogaster deoxynucleoside kinase (DmDnk) 和Bacillus subtilis deoxycytidine kinase (BsDCK) 的修饰的cytidines的酶性酸化.
- 在突变激酶中改变基质特异性的表征.
主要成果:
- 成功的基因酶合成修饰的酸丁单酸盐.
- 创建和测试DmDnk和BsDCK的多个突变变体.
- 识别特定的点突变,显著改变酶基质的特异性,使以前非酸化化合物的酸化.
结论:
- 工程核酸酶表现出改变的基质特异性,扩大了它们的实用性.
- 这种方法有助于合成新型核类相应物,用于潜在的治疗应用.
相关概念视频
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K


